Use of PSA kinetics as a stand-alone test to determine PCa progression, such as in AS programs, yields highly mixed results, but it could be used to trigger further diagnostic intervention such as MRI or saturation biopsy. Here, KLK3 is linked to posterior cortical atrophy.